Validation and Implementation of a Modular Targeted Capture Assay for the Detection of Clinically Significant Molecular Oncology Alterations

被引：0
|
作者：
Kuo, A. J. [1 ]
Paulson, V. A. [1 ]
Hempelmann, J. A. [1 ]
Beightol, M. [1 ]
Todhunter, S. [1 ]
Colbert, B. G. [1 ]
Konnick, E. Q. [1 ]
Pritchard, C. C. [1 ]
Lockwood, C. M. [1 ]
机构：
[1] Univ Washington, Med Ctr, Seattle, WA 98195 USA
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2019年 / 21卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
TT035
引用
收藏
页码：1238 / 1238
页数：1
相关论文
共 50 条
  • [1] Validation and implementation of a modular targeted capture assay for the detection of clinically significant molecular oncology alterations
    Kuo, Ayako J.
    Paulson, Vera A.
    Hempelmann, Jennifer A.
    Beightol, Mallory
    Todhunter, Sheena
    Colbert, Brice G.
    Salipante, Stephen J.
    Konnick, Eric Q.
    Pritchard, Colin C.
    Lockwood, Christina M.
    PRACTICAL LABORATORY MEDICINE, 2020, 19
  • [2] Validation of a Targeted Variant Genotyping Assay for Personalized Oncology Therapy
    Stansberry, W. M.
    Swart, M.
    Medeiros, E. B.
    Skaar, T. C.
    Pratt, V. M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06): : 1018 - 1018
  • [3] Identification and validation of clinically relevant molecular alterations in prostate cancer
    Schlomm, T.
    Sueltmann, H.
    Koellermann, J.
    UROLOGE, 2008, 47 (09): : 1193 - 1198
  • [4] Identification and validation of clinically relevant molecular alterations in prostate cancer
    Schlomm, T.
    Sueltmann, H.
    Koellermann, J.
    PATHOLOGE, 2009, 30 (02): : 111 - 116
  • [5] Validation of Hemolysis Index Thresholds Optimizes Detection of Clinically Significant Hemolysis
    Goyal, Tanu
    Schmotzer, Christine L.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 143 (04) : 579 - 583
  • [6] Comparison of a comprehensive NGS profiling assay and conventional molecular testing approaches for detection of clinically relevant alterations in NSCLC
    Weingartner, Elizabeth
    Gerding, Kelly M. R.
    Cerquiera, Gustavo
    Gault, Christopher
    Hernandez, James
    Valkenburg, Kenneth
    Keefer, Laurel
    Sagini, Eileen
    Johng, Dorhyun
    Gilley, Caitlin
    Ganey, Colby
    Ettehadieh, Leila
    Denier, Diandra
    Oliveras, Christina
    Joshi, Kartikeya
    Kong, Eric
    Papp, Eniko
    Greer, Amy
    White, James R.
    Nichol, Donna
    Simmons, John
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [7] Clinical validation of a novel assay for the detection of diagnostic alterations in sarcomas
    Mc Connell, L.
    Houghton, O.
    Catherwood, M.
    Gazdova, J.
    Stewart, P.
    Oniscu, A.
    Groenen, P.
    Kroeze, L.
    Taniere, P.
    Flanagan, A.
    Stobl, A.
    Salto-Tellez, M.
    De Castro, D. Gonzalez
    ANNALS OF ONCOLOGY, 2019, 30 : 703 - 703
  • [8] DETECTION OF CLINICALLY SIGNIFICANT LOW AVIDITY ERYTHROCYTE ALLOANTIBODIES BY HUMAN MACROPHAGE ASSAY
    SHANFIELD, MS
    BAUMAN, D
    STEVENS, JO
    TRANSFUSION, 1978, 18 (03) : 382 - 382
  • [9] THE DETECTION OF CLINICALLY SIGNIFICANT ERYTHROCYTE ALLOANTIBODIES USING A HUMAN MONONUCLEAR PHAGOCYTE ASSAY
    SCHANFIELD, MS
    STEVENS, JO
    BAUMAN, D
    TRANSFUSION, 1981, 21 (05) : 571 - 576
  • [10] A target capture-based assay for detection of clinically relevant mycobacteria.
    Jucker, MT
    Galarpe, GP
    Lee, SC
    Jonas, V
    CLINICAL CHEMISTRY, 1997, 43 (11) : 54 - 54
12345